Evidence map›Paper›PMID 36817676›Full record

ArticleArchives of medical science : AMS2023

Prognostic role of CD11b

Yue Jiang, Chenxing Wang, Yanling Wang, Wei Zhang, Laikui Liu, Jie Cheng

Open access · goldAbstract read
In one paragraph

Article in Archives of medical science : AMS, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yue JiangJiangsu Key Laboratory of Oral Disease, Nanjing Medical University, Jiangsu, China.
Chenxing WangJiangsu Key Laboratory of Oral Disease, Nanjing Medical University, Jiangsu, China.
Yanling WangJiangsu Key Laboratory of Oral Disease, Nanjing Medical University, Jiangsu, China.
Wei ZhangDepartment of Oral Pathology, Affiliated Stomatological Hospital, Nanjing Medical University, Nanjing, China.
Laikui LiuDepartment of Oral Pathology, Affiliated Stomatological Hospital, Nanjing Medical University, Nanjing, China.
Jie ChengJiangsu Key Laboratory of Oral Disease, Nanjing Medical University, Jiangsu, China.
Nanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Myeloid-derived suppressor cells (MDSCs) are critically involved in cancer immune suppression and MDSC density has been recognized as a robust prognostic biomarker. Here, we sought to characterize the densities and locations of CD11b Material and methods: A total of 144 eligible OSCC samples from a tertiary referral oral cancer center were retrospectively collected. Intensities of CD11b Results: High density of CD11b Conclusions: Our data indicated that increased densities of CD11b

Indexed as

CD11bmyeloid derived suppressor cellsoral squamous cell carcinomaprognostic biomarker

Identifiers

PMID36817676
PMCPMC9897095
OpenAlexW3141774900

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.